Request Sample Inquiry
Orthobiologics Market

Orthobiologics Market

Orthobiologics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

240

Base Year:

2023

Date

Dec - 2024

Format:

PDF XLS PPT

Report Code:

VMR-3760

Segments Covered
  • By Product type By Product type Demineralized Bone Matrix (DBM), Allograft, Bone Morphogenetics Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy
  • By Application By Application Spinal Fusion, Trauma Repair, Reconstructive Surgery
  • By End Use By End Use Hospitals, Outpatient Facilities
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 6.56 Billion
Revenue 2032Revenue 2032: USD 10.4 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 5.9%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Europe
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Orthobiologics Market - Segment Analysis
    1. Overview
    2. Global Orthobiologics Market, 2016 - 2028 (USD Million)
    3. Global Orthobiologics Market - by Product type
      1. By Demineralized Bone Matrix (DBM)
      2. By Allograft
      3. By Bone Morphogenetics Protein (BMP)
      4. By Viscosupplementation
      5. By Synthetic Bone Substitutes
      6. By Stem Cell Therapy
    4. Global Orthobiologics Market - by Application
      1. By Spinal Fusion
      2. By Trauma Repair
      3. By Reconstructive Surgery
    5. Global Orthobiologics Market - by End Use
      1. By Hospitals
      2. By Outpatient Facilities
    6. Global Orthobiologics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Orthobiologics Market - Segment Analysis
    1. Overview
    2. North America Orthobiologics Market, 2016 - 2028 (USD Million)
    3. North America Orthobiologics Market, by Product type
      1. By Demineralized Bone Matrix (DBM)
      2. By Allograft
      3. By Bone Morphogenetics Protein (BMP)
      4. By Viscosupplementation
      5. By Synthetic Bone Substitutes
      6. By Stem Cell Therapy
    4. North America Orthobiologics Market, by Application
      1. By Spinal Fusion
      2. By Trauma Repair
      3. By Reconstructive Surgery
    5. North America Orthobiologics Market, by End Use
      1. By Hospitals
      2. By Outpatient Facilities
    6. North America Orthobiologics Market, by Country
      1. U.S.
        1. U.S. Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. U.S. Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. U.S. Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      2. Canada
        1. Canada Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Canada Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Canada Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      3. Mexico
        1. Mexico Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Mexico Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Mexico Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
  5. Europe Orthobiologics Market - Segment Analysis
    1. Overview
    2. Europe Orthobiologics Market, 2016 - 2028 (USD Million)
    3. Europe Orthobiologics Market, by Product type
      1. By Demineralized Bone Matrix (DBM)
      2. By Allograft
      3. By Bone Morphogenetics Protein (BMP)
      4. By Viscosupplementation
      5. By Synthetic Bone Substitutes
      6. By Stem Cell Therapy
    4. Europe Orthobiologics Market, by Application
      1. By Spinal Fusion
      2. By Trauma Repair
      3. By Reconstructive Surgery
    5. Europe Orthobiologics Market, by End Use
      1. By Hospitals
      2. By Outpatient Facilities
    6. Europe Orthobiologics Market, by Country
      1. Germany
        1. Germany Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Germany Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Germany Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      2. UK
        1. UK Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. UK Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. UK Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      3. France
        1. France Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. France Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. France Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      4. Spain
        1. Spain Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Spain Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Spain Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      5. Italy
        1. Italy Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Italy Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Italy Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      6. BENELUX
        1. BENELUX Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. BENELUX Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. BENELUX Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      7. Rest of Europe
        1. Rest Of Europe Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Rest Of Europe Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Rest Of Europe Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
  6. Asia Pacific Orthobiologics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Orthobiologics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Orthobiologics Market, by Product type
      1. By Demineralized Bone Matrix (DBM)
      2. By Allograft
      3. By Bone Morphogenetics Protein (BMP)
      4. By Viscosupplementation
      5. By Synthetic Bone Substitutes
      6. By Stem Cell Therapy
    4. Asia Pacific Orthobiologics Market, by Application
      1. By Spinal Fusion
      2. By Trauma Repair
      3. By Reconstructive Surgery
    5. Asia Pacific Orthobiologics Market, by End Use
      1. By Hospitals
      2. By Outpatient Facilities
    6. Asia Pacific Orthobiologics Market, by Country
      1. China
        1. China Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. China Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. China Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      2. Japan
        1. Japan Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Japan Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Japan Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      3. India
        1. India Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. India Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. India Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      4. South Korea
        1. South Korea Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. South Korea Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. South Korea Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      5. South East Asia
        1. South East Asia Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. South East Asia Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. South East Asia Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Rest of Asia Pacific Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Rest of Asia Pacific Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
  7. Latin America Orthobiologics Market - Segment Analysis
    1. Overview
    2. Latin America Orthobiologics Market, 2016 - 2028 (USD Million)
    3. Latin America Orthobiologics Market, by Product type
      1. By Demineralized Bone Matrix (DBM)
      2. By Allograft
      3. By Bone Morphogenetics Protein (BMP)
      4. By Viscosupplementation
      5. By Synthetic Bone Substitutes
      6. By Stem Cell Therapy
    4. Latin America Orthobiologics Market, by Application
      1. By Spinal Fusion
      2. By Trauma Repair
      3. By Reconstructive Surgery
    5. Latin America Orthobiologics Market, by End Use
      1. By Hospitals
      2. By Outpatient Facilities
    6. Latin America Orthobiologics Market, by Country
      1. Brazil
        1. Brazil Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Brazil Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Brazil Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      2. Argentina
        1. Argentina Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Argentina Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Argentina Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      3. Rest of Latin America
        1. Rest of Latin America Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Rest of Latin America Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Rest of Latin America Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
  8. Middle East & Africa Orthobiologics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Orthobiologics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Orthobiologics Market, by Product type
      1. By Demineralized Bone Matrix (DBM)
      2. By Allograft
      3. By Bone Morphogenetics Protein (BMP)
      4. By Viscosupplementation
      5. By Synthetic Bone Substitutes
      6. By Stem Cell Therapy
    4. Middle East & Africa Orthobiologics Market, by Application
      1. By Spinal Fusion
      2. By Trauma Repair
      3. By Reconstructive Surgery
    5. Middle East & Africa Orthobiologics Market, by End Use
      1. By Hospitals
      2. By Outpatient Facilities
    6. Middle East & Africa Orthobiologics Market, by Country
      1. GCC Countries
        1. GCC Countries Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. GCC Countries Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. GCC Countries Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      2. South Africa
        1. South Africa Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. South Africa Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. South Africa Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Orthobiologics Market, By Product type
          1. By Demineralized Bone Matrix (DBM)
          2. By Allograft
          3. By Bone Morphogenetics Protein (BMP)
          4. By Viscosupplementation
          5. By Synthetic Bone Substitutes
          6. By Stem Cell Therapy
        2. Rest of Middle East & Africa Orthobiologics Market, By Application
          1. By Spinal Fusion
          2. By Trauma Repair
          3. By Reconstructive Surgery
        3. Rest of Middle East & Africa Orthobiologics Market, By End Use
          1. By Hospitals
          2. By Outpatient Facilities
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Medtronic Plc
    2. DePuy Synthesis
    3. Zimmer Biomet
    4. Stryker Corporation
    5. Anika Therapeutics Inc
    6. Orthofix Inc
    7. Bone Biologics Corp.
    8. Globus Medical
    9. Bioventus LLC
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 03-Jan-2025
FAQ
Frequently Asked Question
  • The global Orthobiologics valued at USD 6.56 Billion in 2023 and is expected to reach USD 10.4 Billion in 2032 growing at a CAGR of 5.9%.

  • The prominent players in the market are Medtronic Plc, DePuy Synthesis, Zimmer Biomet, Stryker Corporation, Anika Therapeutics Inc, Orthofix Inc, Bone Biologics Corp., Globus Medical, Bioventus LLC.

  • The market is project to grow at a CAGR of 5.9% between 2024 and 2032.

  • The driving factors of the Orthobiologics include

  • North America was the leading regional segment of the Orthobiologics in 2023.